PubMed

Early insulin use in type 2 diabetes: what are the cons?

Chiasson JL.

Diabetes Care. 2009 Nov;32 Suppl 2:S270-4. No abstract available. PMID: 19875563 [PubMed - in process]Related articles

Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial.

Hanefeld M, Karasik A, Koehler C, Westermeier T, Chiasson JL.

Diab Vasc Dis Res. 2009 Jan;6(1):32-7.PMID: 19156626 [PubMed - indexed for MEDLINE]Related articles

Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study.

Hammana I, Coderre L, Potvin S, Costa M, Berthiaume Y, Lavoie A, Chiasson JL, Levy E, Rabasa-Lhoret R.

J Cyst Fibros. 2009 Mar;8(2):128-34. Epub 2008 Dec 11.PMID: 19083274 [PubMed - indexed for MEDLINE]Related articles

No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.

Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, Berthiaume Y, Chiasson JL, Coderre L, Rabasa-Lhoret R.

Diabetes Metab. 2008 Dec;34(6 Pt 1):568-73. Epub 2008 Oct 14.PMID: 18922724 [PubMed - indexed for MEDLINE]Related articles

Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of carbohydrates in diabetes): a randomised controlled trial.

Wolever TM, Mehling C, Chiasson JL, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

Diabetologia. 2008 Sep;51(9):1607-15. Epub 2008 Jul 22.PMID: 18648764 [PubMed - indexed for MEDLINE]Related articles

Tissue- and fibre-specific modifications of insulin-signalling molecules in cardiac and skeletal muscle of diabetic rats.

Ekladous D, Mehdi MZ, Costa M, Srivastava AK, Chiasson JL, Coderre L.

Clin Exp Pharmacol Physiol. 2008 Aug;35(8):971-8. Epub 2008 Apr 21.PMID: 18430054 [PubMed - indexed for MEDLINE]Related articles

Increased shear rate resistance and fastest kinetics of erythrocyte aggregation in diabetes measured with ultrasound.

Cloutier G, Zimmer A, Yu FT, Chiasson JL.

Diabetes Care. 2008 Jul;31(7):1400-2. Epub 2008 Mar 28.PMID: 18375419 [PubMed - indexed for MEDLINE]Related articlesFree article

The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.

Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

Am J Clin Nutr. 2008 Jan;87(1):114-25.PMID: 18175744 [PubMed - indexed for MEDLINE]Related articlesFree article

Who should benefit from the use of alpha-glucosidase inhibitors?

Godbout A, Chiasson JL.

Curr Diab Rep. 2007 Oct;7(5):333-9. Review.PMID: 18173965 [PubMed - indexed for MEDLINE]Related articles

Prevention of Type 2 diabetes: fact or fiction?

Chiasson JL.

Expert Opin Pharmacother. 2007 Dec;8(18):3147-58. Review.PMID: 18035959 [PubMed - indexed for MEDLINE]Related articles

Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations.

Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, Corey PN, El-Sohemy A.

Am J Clin Nutr. 2007 Sep;86(3):768-74.PMID: 17823444 [PubMed - indexed for MEDLINE]Related articlesFree article

The TNF-alpha-238G > a single-nucleotide polymorphism protects against memory decline in older adults with type 2 diabetes.

Chui MH, Papanikolaou Y, Fontaine-Bisson B, Turcotte J, Wolever TM, El-Sohemy A, Chiasson JL, Rabasa-Lhoret R, Maheux P, Ryan E, Greenwood CE.

Behav Neurosci. 2007 Jun;121(3):619-24.PMID: 17592954 [PubMed - indexed for MEDLINE]Related articles

Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.

Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, El-Sohemy A.

Metabolism. 2007 May;56(5):649-55.PMID: 17445540 [PubMed - indexed for MEDLINE]Related articles

Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.

Hammana I, Malet A, Costa M, Brochiero E, Berthiaume Y, Potvin S, Chiasson JL, Coderre L, Rabasa-Lhoret R.

Diabetes Metab. 2007 Jun;33(3):213-9. Epub 2007 Apr 5.PMID: 17418606 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.

Costa M, Potvin S, Hammana I, Malet A, Berthiaume Y, Jeanneret A, Lavoie A, Lévesque R, Perrier J, Poisson D, Karelis AD, Chiasson JL, Rabasa-Lhoret R.

J Cyst Fibros. 2007 Nov 30;6(6):376-83. Epub 2007 Apr 3.PMID: 17409029 [PubMed - indexed for MEDLINE]Related articles

Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Andrulionyte L, Kuulasmaa T, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

Diabetes. 2007 Apr;56(4):1181-6. Epub 2007 Feb 22.PMID: 17317762 [PubMed - indexed for MEDLINE]Related articlesFree article

Acute hyperglycemia induces a global downregulation of gene expression in adipose tissue and skeletal muscle of healthy subjects.

Meugnier E, Faraj M, Rome S, Beauregard G, Michaut A, Pelloux V, Chiasson JL, Laville M, Clement K, Vidal H, Rabasa-Lhoret R.

Diabetes. 2007 Apr;56(4):992-9. Epub 2007 Feb 15.PMID: 17303805 [PubMed - indexed for MEDLINE]Related articlesFree article

[Screening and prevention of diabetes]

Chiasson JL.

Perspect Infirm. 2006 Nov-Dec;4(2):18-21. Review. French. No abstract available. PMID: 17184092 [PubMed - indexed for MEDLINE]Related articles

[Role of postprandial hyperglycemia in micro- and macrovascular complications]

Brindisi MC, Rabasa-Lhoret R, Chiasson JL.

Journ Annu Diabetol Hotel Dieu. 2006:79-95. Review. French. No abstract available. PMID: 17051852 [PubMed - indexed for MEDLINE]Related articles

Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K.

Pelletier A, Tardif A, Gingras MH, Chiasson JL, Coderre L.

Mol Cell Biochem. 2007 Feb;296(1-2):97-108. Epub 2006 Sep 8.PMID: 16960657 [PubMed - indexed for MEDLINE]Related articles

Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial.

Andrulionyte L, Laukkanen O, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

J Mol Med. 2006 Aug;84(8):701-8. Epub 2006 Jul 13.PMID: 16838170 [PubMed - indexed for MEDLINE]Related articles

Pharmacological and surgical intervention for the prevention of diabetes.

Chiasson JL.

Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:31-9; discussion 39-42. Review.PMID: 16820729 [PubMed - indexed for MEDLINE]Related articles

Under-utilization of capillary glucose monitoring by type 2 diabetic patients.

Brindisi MC, Hahn J, Chiasson JL, Rabasa-Lhoret R.

Diabetes Res Clin Pract. 2007 Jan;75(1):123-5. Epub 2006 Jun 30.PMID: 16814897 [PubMed - indexed for MEDLINE]Related articles

Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Andrulionyte L, Peltola P, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

Diabetes. 2006 Jul;55(7):2148-52.PMID: 16804087 [PubMed - indexed for MEDLINE]Related articlesFree article

Postprandial hyperglycaemia: to treat or not to treat?

Brindisi MC, Rabasa-Lhoret R, Chiasson JL.

Diabetes Metab. 2006 Apr;32(2):105-11. Review.PMID: 16735958 [PubMed - indexed for MEDLINE]Related articlesFree article

Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial.

Chiasson JL.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:25-30. Review.PMID: 16627376 [PubMed - indexed for MEDLINE]Related articles

Physical training reverses the increased activity of the hepatic ketone body synthesis pathway in chronically diabetic rats.

El Midaoui A, Chiasson JL, Tancrède G, Nadeau A.

Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E207-12.PMID: 16403781 [PubMed - indexed for MEDLINE]Related articlesFree article

The prevention of type 2 diabetes: what is the evidence?

Chiasson JL, Brindisi MC, Rabasa-Lhoret R.

Minerva Endocrinol. 2005 Sep;30(3):179-91. Review.PMID: 16208307 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of acarbose for the management of impaired glucose tolerance in Sweden.

Quilici S, Chancellor J, Maclaine G, McGuire A, Andersson D, Chiasson JL.

Int J Clin Pract. 2005 Oct;59(10):1143-52.PMID: 16178980 [PubMed - indexed for MEDLINE]Related articles

Diabetes: a major co-morbidity of cystic fibrosis.

Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, Levesque R, Chiasson J, Rabasa-Lhoret R.

Diabetes Metab. 2005 Jun;31(3 Pt 1):221-32. Review.PMID: 16142013 [PubMed - indexed for MEDLINE]Related articlesFree article

Alpha-glucosidase inhibitors for patients with type 2 diabetes: response to van de Laar et al.

Hanefeld M, Josse RG, Chiasson JL.

Diabetes Care. 2005 Jul;28(7):1840; author reply 1841. No abstract available. PMID: 15983359 [PubMed - indexed for MEDLINE]Related articlesFree article

Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance.

Zacharova J, Chiasson JL, Laakso M.

Obes Res. 2005 Mar;13(3):501-6.PMID: 15833934 [PubMed - indexed for MEDLINE]Related articles

Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.

Delorme S, Chiasson JL.

Curr Opin Pharmacol. 2005 Apr;5(2):184-9. Review.PMID: 15780829 [PubMed - indexed for MEDLINE]Related articles

Physical training reverses defect in 3-ketoacid CoA-transferase activity in skeletal muscle of diabetic rats.

El Midaoui A, Chiasson JL, Tancrède G, Nadeau A.

Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E748-52.PMID: 15774485 [PubMed - indexed for MEDLINE]Related articlesFree article

The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

Diabetes. 2005 Mar;54(3):893-9.PMID: 15734870 [PubMed - indexed for MEDLINE]Related articlesFree article

The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Zacharova J, Todorova BR, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

J Intern Med. 2005 Feb;257(2):185-93.PMID: 15656877 [PubMed - indexed for MEDLINE]Related articles

Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy.

Zeymer U, Schwarzmaier-D'assie A, Petzinna D, Chiasson JL; STOP-NIDDM Trial Research Group.

Eur J Cardiovasc Prev Rehabil. 2004 Oct;11(5):412-5.PMID: 15616415 [PubMed - indexed for MEDLINE]Related articles

Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.

Andrulionytè L, Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

Diabetologia. 2004 Dec;47(12):2176-84. Epub 2004 Dec 8.PMID: 15592662 [PubMed - indexed for MEDLINE]Related articles

Prevention of type 2 diabetes: insulin resistance and beta-cell function.

Chiasson JL, Rabasa-Lhoret R.

Diabetes. 2004 Dec;53 Suppl 3:S34-8. Review.PMID: 15561919 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR.

Diabetes Care. 2004 Oct;27(10):2356-62.PMID: 15451900 [PubMed - indexed for MEDLINE]Related articlesFree article

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data.

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group.

Diabetologia. 2004 Jun;47(6):969-75; discussion 976-7. Epub 2004 May 26.PMID: 15164169 [PubMed - indexed for MEDLINE]Related articles

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.

Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T.

Stroke. 2004 May;35(5):1073-8. Epub 2004 Apr 8.PMID: 15073402 [PubMed - indexed for MEDLINE]Related articlesFree article

Ketoacidosis and the hyperosmolar hyperglycemic state in adult diabetic patients. Diagnosis and treatment.

Yared Z, Chiasson JL.

Minerva Med. 2003 Dec;94(6):409-18. Review.PMID: 14976469 [PubMed - indexed for MEDLINE]Related articles

The use of information technology for the management of intensive insulin therapy in type 1 diabetes mellitus.

Boukhors Y, Rabasa-Lhoret R, Langelier H, Soultan M, Lacroix A, Chiasson JL.

Diabetes Metab. 2003 Dec;29(6):619-27.PMID: 14707892 [PubMed - indexed for MEDLINE]Related articlesFree article

Nutrition principles and recommendations in diabetes.

Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M; American Diabetes Association.

Diabetes Care. 2004 Jan;27 Suppl 1:S36-46. Review. No abstract available. PMID: 14693924 [PubMed - indexed for MEDLINE]Related articlesFree article

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group.

JAMA. 2003 Jul 23;290(4):486-94.PMID: 12876091 [PubMed - indexed for MEDLINE]Related articlesFree article

[Is prevention of diabetes possible?]

Chiasson JL.

Journ Annu Diabetol Hotel Dieu. 2003:91-7. Review. French. No abstract available. PMID: 12868304 [PubMed - indexed for MEDLINE]Related articles

Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

Chiasson JL, Aris-Jilwan N, Bélanger R, Bertrand S, Beauregard H, Ekoé JM, Fournier H, Havrankova J.

CMAJ. 2003 Apr 1;168(7):859-66. Review. Erratum in: CMAJ. 2003 May 13;168(10):1241. PMID: 12668546 [PubMed - indexed for MEDLINE]Related articlesFree article

Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation.

Tardif A, Julien N, Chiasson JL, Coderre L.

Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1055-64. Epub 2003 Feb 4.PMID: 12569083 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.

Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M; American Diabetes Association.

Diabetes Care. 2003 Jan;26 Suppl 1:S51-61. No abstract available. PMID: 12502619 [PubMed - indexed for MEDLINE]Related articlesFree article